BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 2190527)

  • 1. Hereditary cancer and its clinical implications: a view.
    Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; De Graaf PW; Derkinderen DJ; Hill FW; Huber J; Klein WR
    Anticancer Res; 1990; 10(2B):489-95. PubMed ID: 2190527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenesis by mutations in anti-oncogenes: a view.
    Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; Derkinderen DJ; De Graaf PW; Huber J; Lips CJ; Roholl PJ
    Anticancer Res; 1990; 10(2B):475-87. PubMed ID: 2190526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant inheritance in human cancer.
    Müller H
    Anticancer Res; 1990; 10(2B):505-11. PubMed ID: 2190528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cell-type-specificity of inherited predispositions to tumours: review and hypothesis.
    Bignold LP
    Cancer Lett; 2004 Dec; 216(2):127-46. PubMed ID: 15533589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nakahara memorial lecture. Hereditary cancer, oncogenes, and anti-oncogenes.
    Knudson AG
    Princess Takamatsu Symp; 1989; 20():15-29. PubMed ID: 2577335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and molecular aspects of human multigenerational carcinogenesis.
    Evans HJ
    IARC Sci Publ; 1989; (96):315-33. PubMed ID: 2553599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic pathways in hereditary and sporadic breast cancer.
    Kenemans P; Verstraeten RA; Verheijen RH
    Maturitas; 2004 Sep; 49(1):34-43. PubMed ID: 15351094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumours of familial origin in the head and neck.
    Suárez C; Rodrigo JP; Ferlito A; Cabanillas R; Shaha AR; Rinaldo A
    Oral Oncol; 2006 Nov; 42(10):965-78. PubMed ID: 16857415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary neoplastic diseases (genetic predisposition and cancer syndromes)].
    Oláh E
    Orv Hetil; 1999 Feb; 140(9):451-66. PubMed ID: 10204401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial cancer. A review on hereditary cancer traits with special regard to colorectal carcinoma.
    Järvinen HJ
    Acta Oncol; 1988; 27(6b):783-6. PubMed ID: 3069120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new model for oncogenesis. From tumour immunology to a mathematical approach of oncogenesis.
    Den Otter W; Koten JW; Derkinderen DJ
    Anticancer Res; 1986; 6(3 Pt B):509-14. PubMed ID: 3740800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hereditary carcinoma: pathogenesis and diagnosis].
    Jungck M
    Zentralbl Chir; 2000; 125 Suppl 1():8-11. PubMed ID: 10929639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The involvement of oncogenes and suppressor genes in human neoplasia.
    Brodeur GM
    Adv Pediatr; 1987; 34():1-44. PubMed ID: 3318293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to cancer. ICRP publication 79. Approved by the Commission in May 1997. International Commission on Radiological Protection.
    Ann ICRP; 1998; 28(1-2):1-157. PubMed ID: 10406427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
    Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
    Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular therapy in malignant tumors].
    Fey MF
    Schweiz Med Wochenschr; 1999 Nov; 129(46):1758-63. PubMed ID: 10603649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of BRCA2 mutations in breast carcinoma and other cancers.
    Teng DH; Bogden R; Mitchell J; Baumgard M; Bell R; Berry S; Davis T; Ha PC; Kehrer R; Jammulapati S; Chen Q; Offit K; Skolnick MH; Tavtigian SV; Jhanwar S; Swedlund B; Wong AK; Kamb A
    Nat Genet; 1996 Jun; 13(2):241-4. PubMed ID: 8640236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.